ENGEN BIO
EnGen Bio is a development-stage biotechnology company that pioneers a new approach to preventing and treating influenza. It believes that it has identified a candidate Universal Type A Influenza vaccine. Influenza drugs and vaccines are unique because there is sufficient government funding available to develop these assets well into human clinical trials, and possibly to market. EnGen Bio is aggressively pursuing this and similar opportunities. It is founded in 2017 and is headquartered in Redwood City, California.
ENGEN BIO
Industry:
Biotechnology Health Care Health Diagnostics Life Science
Founded:
2016-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.engenbio.com
Total Employee:
11+
Status:
Active
Total Funding:
812 K USD
Similar Organizations
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Current Employees Featured
Founder
Investors List
National Science Foundation
National Science Foundation investment in Grant - EnGen Bio
Official Site Inspections
http://www.engenbio.com
- Host name: 104.237.12.198.host.secureserver.net
- IP address: 198.12.237.104
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
